NOVA2 and neurodegenerative disease: Neuro-oncological ventral antigen 2 (Nova2), a neuronal-specific RNA binding protein, was first identified as an autoimmune antigens in the neurodegenerative disease POMA (paraneoplastic opsoclonus myoclonus ataxia).